We're excited to share a significant milestone with you all. The annual release of Clarivate’s Journal Citation Report (JCR) revealed that The Cureus Journal of Medical Science has been awarded its first Impact Factor (IF). This is a noteworthy achievement for our community, and we are proud to share it with you.

Both the 2022 two-year IF and five-year IF are 1.2. These Impact Factors place us in the mid-ranking for medicine, a commendable achievement for a journal that prides itself on inclusivity and accessibility.

Impact Factors, alongside other metrics such as turnaround time, downloads and social media mentions can help to provide an overall assessment of journal quality and its research output in the community.

Cureus metrics:

• Average Submission to Publication Time: 33 Days

• Total 2022 Article Views: 40.5 Million

• Articles Published for Free: 31%

While we celebrate this achievement, we wish to restate that Cureus is a DORA signatory and reaffirm our commitment to assessing individual research articles on their own merits, rather than on an aggregate citation count for the journal. This is why we provide article-level metrics on every article page. We understand the importance of Impact Factor to many in the academic community, and as an academic publisher closely attuned to the needs of the research community, we acknowledge its significance.

We believe that our inclusion in the Web of Science, and the subsequent Impact Factors, will be beneficial for many academics whose research output is still measured by metrics such as IF. We hope that, alongside this information, our article-level metrics and transparent publishing process will encourage more physicians and medical researchers to submit their work to Cureus, and thus benefit from broad readership and high-quality peer review.

Your contributions, whether as authors, reviewers, or readers, have played a crucial role in this accomplishment. We encourage you to continue with us on our journey to democratize medical publishing.

- The Cureus Team